ArticleFrontiers in immunology2025
Sex-specific associations between systemic autoantibodies and allergic sensitization or allergic disease - results from a population-based study.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: So far, knowledge of determinants of the presence of systemic autoantibodies (AABs) in the population is limited. Here, we investigated possible associations between serum AABs and allergies, using data on allergic sensitization and diagnoses of allergic diseases. Methods: In 331 participants of a population-based study, 5 humoral systemic AABs and 7 AAB screening tests were analyzed. Allergic sensitization was characterized by specific IgE concentrations in serum samples (CAP class ≥ 2); additionally, self-reported diagnoses of allergic diseases were used as exposure variables. Multivariable adjusted logistic regression models were applied to explore the association with AAB test positivity; all analyses were stratified by sex. In a sensitivity analysis, AAB test results were defined as non-normal and normal. Results: In 46.2% and 37.1% of female and male study participants, respectively, at least one positive AAB test was identified. Allergic sensitization was observed in 23.8% and 29.7% of female and male participants, while 26.2% and 9.3% reported at least one diagnosis of allergic disease, respectively. Positive associations between allergic sensitization and serum AABs were identified in women for rheumatoid factor (RF), antinuclear antibodies (ANA), and at least one positive AAB test; in men, there was some indication for an association with anti-neutrophil cytoplasmic antibody (ANCA) positivity. Self-reported diagnosis of allergic diseases was not significantly associated with the AAB positivity. Conclusion: In this population-based group of adults, there is evidence for an association between allergic sensitization and systemic AABs, almost exclusively in women. Large prospective studies are needed for confirmation and further investigation of individual AABs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.